Project Grant R01DA060240
Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $795K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to optimize opioid use disorder (OUD) treatment in prisons. The key products and services to be delivered include: Validating a 2-item OUD screening tool and an 11-item diagnostic DSM-5 OUD symptom checklist adapted for use in prisons. This will involve validating these tools against...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study to characterize treatment utilization and identify predictors of treatment engagement during the critical community re-entry period for adults with opioid use disorder (OUD) who have completed residential OUD treatment. The $147,486 award, with a performance period from December 20, 2024 to August 31, 2026, will leverage innovative...
- The National Institute on Drug Abuse (NIDA) awarded a 4.75-year, $1,541,502 Project Grant to Oregon Health & Science University (OHSU) under the Drug Use and Addiction Research Programs (CFDA 93.279) to study the impact of telehealth expansion on opioid use disorder (OUD) care delivery within community health centers. The project aims to evaluate patterns of telephone, video, and in-person visits for OUD treatment and identify multi-level characteristics associated with the use of each...
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a 5-year, $187,164 research project at Temple University to study the impact of Medicaid "Institutions for Mental Diseases" (IMD) waivers on the utilization of medications for opioid use disorder (MOUD) treatment. The key objectives are to: 1) characterize IMD waiver features across jurisdictions to enable comparison, 2) measure the...
- The University of Florida received a $779,327 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) on August 15, 2025. The grant, titled "Prediction of Relapse on OUD Treatment Using Machine Learning-Driven Evidence-Based Clinical Decision Support Tool (PROTECT)", aims to develop a machine learning-based clinical decision support tool to help primary care practitioners identify patients with opioid use disorder (OUD) who...